Rayner
Gary Moxon has a diverse work experience spanning several companies and roles. Gary recently joined Rayner as a Quality Engineer in October 2022. Prior to this, they worked at Jankel as a Quality Engineer from April 2019 to October 2022. Before that, they were a Project Risk Manager at MSI - ARTF in Afghanistan from March 2018 to March 2019. From January 2015 to March 2019, they worked as a Consultant at GardaWorld. Gary also served as a Security and Risk Manager for the International Relief and Development (IRD) project EQUALS from March 2014 to January 2016, and as a Program Security & Risk Manager for the IRD ARTF World Bank project from December 2012 to March 2014. Gary Moxon gained experience in logistics and materials as a Senior Project Engineer at Weatherford in Iraq-Garraf Field Development Project-FCP from May 2012 to an unspecified end date. Gary previously worked as an Operations Security Manager at TA'AZ Security from January 2012 to June 2012, and as a Security Manager for Weatherford at TA'AZ Group from July 2011 to January 2012. Before that, they served as the 1st Team Lead - 2nd Hostile Environment Trauma Life Support Medic at TA'AZ from June 2011 to November 2011.
Gary Moxon attended the Princes Marina Army School of Engineering from 1994 to 1996, where they obtained a Higher National Diploma (HND) in Engineering Materials. No further information is available about any additional certifications.
This person is not in any offices
Rayner
5 followers
Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. Weare focused on providing the best IOLs for clinicians and patients and are driven by science to improve patient outcomes and safety.Primary IOLs Our FDA-approved C-flex aspheric (aberration-neutral) monofocal IOL, as well as our toric and multifocal IOL families are now complemented by the RayOne fully preloaded monofocal IOL injection system. Supplementary IOLsDesigned to be implanted in the ciliary sulcus, Rayner Sulcoflex Pseudophakic Supplementary IOLs are available as aspheric, toric, multifocal and multifocal lenses, and offer a reversible solution for correcting residual post-operative refractive errors following the implantation of a conventional IOL in the capsular bag.OVDsOur Ophteis range offers a full spectrum of OVDs from dispersive to cohesive, enabling surgeons to select the OVD best suited to each specific cataract procedure. Ophteis FR Pro with sorbitol -- designed to deliver a new level of corneal endothelial protection from phaco induced trauma -- is the flagship product of Rayner’s ‘Ophteis’ OVD suite. PharmaceuticalsAlthough the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result. For that reason, Rayner recently acquired the business of Moorfields Pharmaceuticals. The acquisition will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient.Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 80 countries with direct markets in UK, Germany & Austria, the United States of America, Italy and Spain. We have the world’s longest commercial history of IOL design and manufacturing and have worked with cataract surgeons for longer than anyone else.In 2016, Rayner transferred its global headquarters to a brand new state of the art manufacturing plant, which has dramatically increased the company’s production capacity.